Ashley Graham1, William Bartle2, Patti Madorin3, Vincent Teo4, Artemis Diamantouros5. 1. , PharmD, ACPR, was, at the time of this study, a pharmacy resident at the Sunnybrook Health Sciences Centre, Toronto, Ontario. She is now with Women's College Hospital, Toronto, Ontario. 2. , BScPhm, PharmD, FCSHP, is with the Sunnybrook Health Sciences Centre, Toronto, Ontario. 3. , BScPhm, ACPR, is with the Sunnybrook Health Sciences Centre, Toronto, Ontario. 4. , BScPhm, PharmD, ACPR, is with the Sunnybrook Health Sciences Centre, Toronto, Ontario. 5. , BScPhm, MEd, PhD (deceased), was with the Sunnybrook Health Sciences Centre, Toronto, Ontario.
Abstract
BACKGROUND: The Ontario MedsCheck program was introduced in April 2007, with enhancements to strengthen the program made in October 2016. Previous literature has characterized patients who received the service before the enhancements and described the experiences of community pharmacists and physicians, but the experiences of participants in the enhanced MedsCheck program and those of hospital pharmacists and pharmacy technicians have not been explored. OBJECTIVES: This study was designed to describe and compare the demographic and clinical characteristics of patients admitted to Sunnybrook Health Sciences Centre (SHSC) who had received a MedsCheck before and after the program enhancements of 2016. The study also aimed to describe the experiences of patients, hospital pharmacists, and pharmacy technicians with the MedsCheck program. METHODS: Chart reviews were completed to identify and characterize patients who had received a MedsCheck and were admitted to SHSC between March and May 2016 (retrospective cohort) and between March and May 2017 (prospective cohort). Patients were interviewed and focus groups were conducted with pharmacy staff to explore their experiences with the MedsCheck program. RESULTS: MedsChecks had been performed for 321 (14.5%) of 2216 patients in the retrospective cohort and 172 (6.8%) of 2547 patients in the prospective cohort, an absolute decline of 7.7% after the 2016 enhancements. Patient characteristics were similar between the 2 cohorts. Patients' experiences were varied, but because of low enrolment in the interview process (n = 3), it was difficult to identify and summarize common themes. The analysis of focus groups involving pharmacy staff (n = 27 participants) revealed that the benefits of MedsChecks depended on quality and access, and also identified common barriers and opportunities for future enhancements. CONCLUSIONS: Patient interviews revealed the features of the program that patients valued. Pharmacy staff identified several benefits and barriers encountered when using MedsChecks. These findings can guide clinicians in optimal application of the current MedsCheck program and can inform subsequent program revisions.
BACKGROUND: The Ontario MedsCheck program was introduced in April 2007, with enhancements to strengthen the program made in October 2016. Previous literature has characterized patients who received the service before the enhancements and described the experiences of community pharmacists and physicians, but the experiences of participants in the enhanced MedsCheck program and those of hospital pharmacists and pharmacy technicians have not been explored. OBJECTIVES: This study was designed to describe and compare the demographic and clinical characteristics of patients admitted to Sunnybrook Health Sciences Centre (SHSC) who had received a MedsCheck before and after the program enhancements of 2016. The study also aimed to describe the experiences of patients, hospital pharmacists, and pharmacy technicians with the MedsCheck program. METHODS: Chart reviews were completed to identify and characterize patients who had received a MedsCheck and were admitted to SHSC between March and May 2016 (retrospective cohort) and between March and May 2017 (prospective cohort). Patients were interviewed and focus groups were conducted with pharmacy staff to explore their experiences with the MedsCheck program. RESULTS: MedsChecks had been performed for 321 (14.5%) of 2216 patients in the retrospective cohort and 172 (6.8%) of 2547 patients in the prospective cohort, an absolute decline of 7.7% after the 2016 enhancements. Patient characteristics were similar between the 2 cohorts. Patients' experiences were varied, but because of low enrolment in the interview process (n = 3), it was difficult to identify and summarize common themes. The analysis of focus groups involving pharmacy staff (n = 27 participants) revealed that the benefits of MedsChecks depended on quality and access, and also identified common barriers and opportunities for future enhancements. CONCLUSIONS: Patient interviews revealed the features of the program that patients valued. Pharmacy staff identified several benefits and barriers encountered when using MedsChecks. These findings can guide clinicians in optimal application of the current MedsCheck program and can inform subsequent program revisions.
Authors: Andrea C Bishop; Todd A Boyle; Bobbi Morrison; James R Barker; Bev Zwicker; Tom Mahaffey; Andrea Murphy Journal: Can Pharm J (Ott) Date: 2015-09
Authors: Lisa Dolovich; Giulia Consiglio; Linda MacKeigan; Lusine Abrahamyan; Petros Pechlivanoglou; Valeria E Rac; Nedzad Pojskic; Elizabeth A Bojarski; Jiandong Su; Murray Krahn; Suzanne M Cadarette Journal: Can Pharm J (Ott) Date: 2016-08-09